Johnson & Johnson
Explore Johnson & Johnson
Core profile pages, annual revenue records, and related research hubs for this company.
CorpDigest
Johnson & Johnson
Explore Johnson & Johnson
Core profile pages, annual revenue records, and related research hubs for this company.
Annual Revenue
FY2023 Revenue
$85.2B
▼ 9.2% vs FY2022 ($93.8B)
Source: Annual report / company filing
Johnson & Johnson reported $85.2B in revenue for fiscal year 2023. This represents a decline of 9.2% compared to the 2022 figure of $93.8B. In 2024, revenue increased to $88.8B.
The 2023 completion of the Kenvue consumer-health spinoff removed that segment's revenue, contributing to a roughly 9.2% decline to $85.159 billion for the newly focused pharma and MedTech company.
| Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2025 | $94.2B | — | +6.0% |
| FY2024 | $88.8B | $13.3B | +4.3% |
| FY2023 | $85.2B | — | -9.2% |
| FY2022 | $93.8B | — | +0.0% |
| FY2021 | $93.8B | — | +13.6% |
| FY2020 | $82.6B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.